FDA
approval
· 2025-03-17
FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)
Summary
The FDA approved a supplemental application for Amnesteem (isotretinoin) submitted by Mylan Pharmaceuticals. This represents an approved addition or modificatio…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMNESTEEM (ISOTRETINOIN)